
|Articles|September 15, 2008
Phaco philosophy: consider IOL exchange pearls, practicalities
Exchanging an IOL is the only choice when the optical clarity of the implant is compromised by internal calcification or glistenings.
Advertisement
Key Points
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
FDA approves NDA labeling supplement allowing re-administration of iDose TR
3
Opus Genetics launches phase 1/2 MERTK gene therapy trial
4
FDA Type C meeting supports phase 2b/3 pathway for urcosimod in neuropathic corneal pain
5



























